Med-Mastodon

0 posts0 participants0 posts today

Mark MartinoThe new tariffs imposed include a 26% tariff on India. Half of all generic medicines in the US are from India. This will impact 9 out of 10 prescriptions. <a href="https://mastodon.online/tags/prescriptions" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#prescriptions</a> <a href="https://mastodon.online/tags/tariffs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#tariffs</a> <a href="https://mastodon.online/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a>

Chris Engelbert / noctariusMe: I love the possibilities of generics in Typescript.Also me: I hate the possibilities of generics in Typescript.<a href="https://mastodon.online/tags/typescript" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#typescript</a> <a href="https://mastodon.online/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://mastodon.online/tags/coding" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#coding</a>

ajaxStardustThe takeaway? Note the Dr's replies (dates between my outgoing). You are correct. There are none. If nothing else, maybe BOOST it?This is my attempt to communicate important life changing information to my primary care physician, of the Geisinger Family Health Network, in State College, Pennsylvania, 16803. In JULY 2024. I'm still waiting for his reply. <a href="https://social.vivaldi.net/tags/Lyrica" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Lyrica</a> <a href="https://social.vivaldi.net/tags/Pregabalin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Pregabalin</a> <a href="https://social.vivaldi.net/tags/Gabapentin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Gabapentin</a> <a href="https://social.vivaldi.net/tags/Civilrights" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Civilrights</a> <a href="https://social.vivaldi.net/tags/CivilProtection" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CivilProtection</a> <a href="https://social.vivaldi.net/tags/medicalmalpractice" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicalmalpractice</a> <a href="https://social.vivaldi.net/tags/FBI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#FBI</a> <a href="https://social.vivaldi.net/tags/Fraud" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Fraud</a> <a href="https://social.vivaldi.net/tags/Pfizer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Pfizer</a> <a href="https://social.vivaldi.net/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://social.vivaldi.net/tags/phamaceutical" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#phamaceutical</a> <a href="https://social.vivaldi.net/tags/pharmacy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pharmacy</a> <a href="https://social.vivaldi.net/tags/braindamage" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#braindamage</a>

stateful beingnot even kidding about the <a href="https://mastodon.social/tags/10years" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#10years</a> <a href="https://github.com/rust-lang/rust/issues/19032" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://github.com/rust-lang/rust/issues/19032</a> dates from 2014as do my intentions to write this program, come to think of it<a href="https://mastodon.social/tags/rust" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#rust</a> <a href="https://mastodon.social/tags/static" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#static</a> <a href="https://mastodon.social/tags/typing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#typing</a> <a href="https://mastodon.social/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://mastodon.social/tags/wtf" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#wtf</a> <a href="https://mastodon.social/tags/srsly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#srsly</a>

EURACTIV HealthNetherlands should raise generics prices to combat drug shortages, says Dutch bank [Advocacy Lab Content] <a href="https://www.euractiv.com/section/health-consumers/news/netherlands-should-raise-generics-prices-to-combat-drug-shortages-says-dutch-bank/?utm_source=dlvr.it&utm_medium=mastodon" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.euractiv.com/section/health-consumers/news/netherlands-should-raise-generics-prices-to-combat-drug-shortages-says-dutch-bank/?utm_source=dlvr.it&utm_medium=mastodon</a> <a href="https://eupolicy.social/tags/EUPharmaPackage" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EUPharmaPackage</a> <a href="https://eupolicy.social/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://eupolicy.social/tags/MedicinesPricing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MedicinesPricing</a> <a href="https://eupolicy.social/tags/Netherlands" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Netherlands</a>

Daniël Franke 🏳️‍🌈It's hard to imagine that I could ever write <a href="https://berlin.social/tags/Golang" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Golang</a> without <a href="https://berlin.social/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a>.

Jaanus Kase<a href="https://iosdev.space/tags/Swift" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Swift</a> <a href="https://iosdev.space/tags/Generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Generics</a>Hello my beautiful kind helpful Swift peopleI have basic question about generics, “some”, “any” and such. Maybe you can nudge me in the right direction?How would you fix this code so it compiles? Can it be done even?What it does: trying to archive and unarchive some Codable+Sendable values, without caring about the exact typeIt can assume that there are no mixed types, i.e it always works with [ResultRecord] or [OtherTypeConformingToResultRecordType], but no mixing

Naomi T.🤩 Cool event in 2025! Laure Gardelle and I are co-organizing an international conference on “Generics and stereotypes in discourse: a cross-disciplinary perspective” at Leiden University, 5-6 June 2025. The CfP is now out!<a href="https://www.staff.universiteitleiden.nl/events/2025/06/generics-and-stereotypes" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.staff.universiteitleiden.nl/events/2025/06/generics-and-stereotypes</a><a href="https://mas.to/tags/Conference" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Conference</a> <a href="https://mas.to/tags/Leiden" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Leiden</a> <a href="https://mas.to/tags/Generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Generics</a> <a href="https://mas.to/tags/Stereotypes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Stereotypes</a>

🧿🪬🍄🌈🎮💻🚲🥓🎃💀🏴🛻🇺🇸typescript considered harmful<a href="https://mastodon.social/tags/webdev" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#webdev</a> <a href="https://mastodon.social/tags/typescript" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#typescript</a> <a href="https://mastodon.social/tags/web" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#web</a> <a href="https://mastodon.social/tags/programming" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#programming</a> <a href="https://mastodon.social/tags/types" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#types</a> <a href="https://mastodon.social/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://mastodon.social/tags/javaScript" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#javaScript</a>

EURACTIV HealthTop EU court upholds Commission’s decision on anti-competitive behaviour in perindopril market <a href="https://www.euractiv.com/section/health-consumers/news/top-eu-court-upholds-commissions-decision-on-anti-competitive-behaviour-in-perindopril-market/?utm_source=dlvr.it&utm_medium=mastodon" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.euractiv.com/section/health-consumers/news/top-eu-court-upholds-commissions-decision-on-anti-competitive-behaviour-in-perindopril-market/?utm_source=dlvr.it&utm_medium=mastodon</a> <a href="https://eupolicy.social/tags/cartel" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#cartel</a> <a href="https://eupolicy.social/tags/competition" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#competition</a> <a href="https://eupolicy.social/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://eupolicy.social/tags/monopoly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#monopoly</a> <a href="https://eupolicy.social/tags/pharmacuetical" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pharmacuetical</a>

Dominic TyerCalifornia to sell state-branded Narcan generic to cut costs<a href="https://pharmaphorum.com/news/california-sell-state-branded-narcan-generic-cut-costs" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://pharmaphorum.com/news/california-sell-state-branded-narcan-generic-cut-costs</a><a href="https://mas.to/tags/pharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pharma</a> <a href="https://mas.to/tags/Narcan" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Narcan</a> <a href="https://mas.to/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://mas.to/tags/California" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#California</a>

SherBeareth<a href="https://mastodon.world/tags/highwayrobbery" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#highwayrobbery</a> <a href="https://mastodon.world/tags/FightBigPharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#FightBigPharma</a> <a href="https://mastodon.world/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> Amen to this confession going public. Big Pharma has us by the proverbial short hairs.

healthnotesAn amazing story from STAT's Bob Herman showing how <a href="https://med-mastodon.com/tags/PBMs" class="mention hashtag" rel="tag">#PBMs</a> protect their profits even when cheaper <a href="https://med-mastodon.com/tags/generics" class="mention hashtag" rel="tag">#generics</a> or <a href="https://med-mastodon.com/tags/biosimilars" class="mention hashtag" rel="tag">#biosimilars</a> reach the market. As <a href="https://med-mastodon.com/tags/Humira" class="mention hashtag" rel="tag">#Humira</a> biosimilars take over the market, $CVS has created a new ploy: the drug ‘rebate credit’ <a href="https://med-mastodon.com/tags/rebatecredit" class="mention hashtag" rel="tag">#rebatecredit</a> <a href="https://www.statnews.com/2024/03/18/humira-pbms-cvs-caremark-rebate-credits/" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://www.statnews.com/2024/03/18/humira-pbms-cvs-caremark-rebate-credits/</a>

Paul Houle🦻 Experimental gene therapy allows kids with inherited deafness to hear<a href="https://medicalxpress.com/news/2024-01-experimental-gene-therapy-kids-inherited.html" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://medicalxpress.com/news/2024-01-experimental-gene-therapy-kids-inherited.html</a><a href="https://mastodon.social/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://mastodon.social/tags/gmo" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#gmo</a> <a href="https://mastodon.social/tags/genetherapy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#genetherapy</a> <a href="https://mastodon.social/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicine</a> <a href="https://mastodon.social/tags/health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#health</a> <a href="https://mastodon.social/tags/hearing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#hearing</a> <a href="https://mastodon.social/tags/deafness" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#deafness</a> <a href="https://mastodon.social/tags/disability" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#disability</a>

ÖlbaumSo I learned <a href="https://tooting.ch/tags/GoLang" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GoLang</a> yesterday, and today I managed to write functions for filter and map with <a href="https://tooting.ch/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> on the first try. Feels good. I was a bit surprised they’re not available out of the box, though.I like generics, is it serious, doctor?

International Patent ReviewsIn a precedential opinion the CAFC upheld the rights of generic manufacturers to carve out methods of use on patented drugs saying “a brand could ‘maintain its exclusivity merely by regularly filing a new patent application claiming a narrow method of use not covered by its NDA,’ which ‘would confer substantial additional rights on" the <a href="https://mastodon.cloud/tags/pharmaceutical" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pharmaceutical</a> company.This is a significant holding against patent evergreening by <a href="https://mastodon.cloud/tags/bigpharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#bigpharma</a>.<a href="https://cafc.uscourts.gov/opinions-orders/22-1194.OPINION.12-7-2023_2234246.pdf" rel="nofollow noopener noreferrer" target="_blank">https://cafc.uscourts.gov/opinions-orders/22-1194.OPINION.12-7-2023_2234246.pdf</a><a href="https://mastodon.cloud/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://mastodon.cloud/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a> <a href="https://mastodon.cloud/tags/OrangeBook" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#OrangeBook</a>

International Patent ReviewsFrom Reuters: "Exclusive: Drugmakers set to raise US prices on at least 500 drugs in January"<a href="https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-set-raise-us-prices-least-500-drugs-january-2023-12-29/" rel="nofollow noopener noreferrer" target="_blank">https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-set-raise-us-prices-least-500-drugs-january-2023-12-29/</a><a href="https://mastodon.cloud/tags/pharmaceuticals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pharmaceuticals</a> <a href="https://mastodon.cloud/tags/BigPharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#BigPharma</a> <a href="https://mastodon.cloud/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#patents</a> <a href="https://mastodon.cloud/tags/OrangeBook" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#OrangeBook</a> <a href="https://mastodon.cloud/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a>

Mstdn Kirt<a href="https://toot.community/@peachfront" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@peachfront</a> <a href="https://med-mastodon.com/@luckytran" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@luckytran</a> <a href="https://zeroes.ca/@kirt" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@kirt@zeroes.ca</a> <a href="https://mastodon.social/@kirt" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@kirt@mastodon.social</a> The key step is to publicly fund clinical trials and keep it IP free.Then drug manufacturing could be public or private generics or a mix of the two as-needed.And you don't need to nationalise the whole company, just compulsory licensing of IP, which is often suggested, even in this pandemic. IP is the thing you need, being intangible helps.But I'm being boring?cc other mes <a href="https://med-mastodon.com/@kirt" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@kirt@med-mastodon.com</a> <a href="https://zeroes.ca/@kirt" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@kirt@zeroes.ca</a> <a href="https://mastodon.social/@kirt" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@kirt@mastodon.social</a> <a href="https://mstdn.social/tags/ip" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ip</a> <a href="https://mstdn.social/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://mstdn.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrials</a> <a href="https://mstdn.social/tags/PubliclyFundClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PubliclyFundClinicalTrials</a>

Sean MurthyCreating a Generic Array in Java.Browsed it. Well organized, has source code on GitHub. Will read carefully later.<a href="https://www.baeldung.com/java-generic-array" rel="nofollow noopener noreferrer" target="_blank">https://www.baeldung.com/java-generic-array</a><a href="https://hachyderm.io/tags/java" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#java</a> <a href="https://hachyderm.io/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> <a href="https://hachyderm.io/tags/arrays" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#arrays</a>

Christian Tietze<a href="https://mastodon.social/tags/Swift" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Swift</a> <a href="https://mastodon.social/tags/generics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#generics</a> / opaque type question:Say I have this, a "Lens" to represent a typed getter:protocol ReadonlyLens<Whole, Part> { associatedtype Whole associatedtype Part var get: (Whole) -> Part { get } } struct Lens<Whole, Part>: ReadonlyLens { let get: (Whole) -> Part }Let's say I want to apply it tostruct Person { let name: String let age: Int }... can I compare two person via Lens<Person,String> (name) & Lens<Person,Int> (age) via Lens<Person,Equatable>?

Recent searches

Search options

Administered by:

Server stats:

#generics